KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Esperion Therapeutics (ESPR) Return on Equity: 2019-2024

Historic Return on Equity for Esperion Therapeutics (ESPR) over the last 6 years, with Dec 2024 value amounting to 0.01%.

  • Esperion Therapeutics' Return on Equity rose 13.00% to 0.24% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.24%, marking a year-over-year increase of 13.00%. This contributed to the annual value of 0.01% for FY2024, which is 54.00% down from last year.
  • Esperion Therapeutics' Return on Equity amounted to 0.01% in FY2024, which was down 97.91% from 0.55% recorded in FY2023.
  • In the past 5 years, Esperion Therapeutics' Return on Equity registered a high of 3.78% during FY2020, and its lowest value of 0.01% during FY2024.
  • Moreover, its 3-year median value for Return on Equity was 0.55% (2023), whereas its average is 0.49%.
  • As far as peak fluctuations go, Esperion Therapeutics' Return on Equity skyrocketed by 583bps in 2020, and later plummeted by 192bps in 2021.
  • Yearly analysis of 5 years shows Esperion Therapeutics' Return on Equity stood at 3.78% in 2020, then plummeted by 192bps to 1.86% in 2021, then crashed by 96bps to 0.91% in 2022, then crashed by 36bps to 0.55% in 2023, then crashed by 54bps to 0.01% in 2024.